Vista Pharmaceuticals Ltd — Results, 30-05-2025: Result

Vista Pharmaceuticals Limited has announced a board meeting outcome approving the financial results for the quarter and half-year ended 31.03.2025, accompanied by an unmodified auditor’s opinion. The company appointed M/s. LMN & Co. as Internal Auditors for FY 2025-26 and M/s. Aakansha Dubey & Co. as Secretarial Auditors for five years starting FY 2025-26. Revenue from operations rose to Rs. 323.00 lakhs for the quarter, with a net loss narrowing to Rs. 100.21 lakhs. Total assets increased to Rs. 60.29 Cr, supported by steady equity growth. The company reported a cash outflow from operations, reflecting ongoing investment in working capital.